REZOLUTE INC Chart calendar Rezolute Inc
1308d8205255e051c334.U2XrkSyqD7DujQl9K0zFCH_89_GcFaXlmyoMRjPoe_U.ABDe_mnAePuGvGMNbi2VfEy7uZb_evCQ4m5TDnuCFsEJIafrGe9s_oXhQA~d8a498004a91e5df06270772d6a5f2a1
Upcoming events on Rezolute Inc
Past events on Rezolute Inc
| Today | Q3 2024 Earnings Release (Projected) |
| 04/05/2024 10:45 pm | Pediatric Endocrine Society Meeting - Abstract No : 6790 |
| 14/02/2024 02:35 am | Q2 2024 Earnings Release |
| 28/11/2023 01:00 am | BTIG Ophthalmology Day |
| 14/11/2023 02:35 am | Q1 2024 Earnings Release |
| 26/09/2023 11:40 pm | Cantor Global Healthcare Conference |
| 15/09/2023 01:35 am | Q4 2023 Earnings Release |
| 12/09/2023 11:30 pm | H.C. Wainwright Global Investment Conference |
| 28/06/2023 02:00 am | RZ358 Phase3 Update Call |
| 26/05/2023 03:30 am | Annual General Meeting |
| 12/05/2023 01:35 am | Q3 2023 Earnings Release |
| 23/03/2023 02:00 am | Investor Meeting - Key Opinion Leader |
| 11/02/2023 02:35 am | Q2 2023 Earnings Release |
| 17/11/2022 09:55 pm | Jefferies London Healthcare Conference |
| 10/11/2022 02:35 am | Q1 2023 Earnings Release |
| 03/11/2022 11:17 pm | Retina Society Scientific Meeting |
| 16/09/2022 01:35 am | FY 2022 Earnings Release |
| 15/09/2022 06:25 pm | European Society for Paediatric Endocrinology Conference - Abstract Code FC3.2 |
| 17/06/2022 03:30 am | Annual General Meeting |
| 13/05/2022 01:35 am | Q3 2022 Earnings Release |
Annual results
| Fiscal Period | Juni | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -25,9 -31,3 17.11% | 0,00 0,00 - | -22,9 -22,5 -1.68% | -41,8 -45,1 7.27% | -56,0 -60,0 6.65% | -65,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -30,4 -35,8 14.96% | 0,00 0,00 - | -20,9 -22,1 5.26% | -41,1 -46,7 12.08% | -51,8 -58,0 10.74% | -61,8 |
|
Net income Million USD | Released Forecast Spread | -30,4 -35,8 14.96% | -20,3 -21,8 6.73% | -20,9 -21,6 3.15% | -41,1 -46,7 12.08% | -51,8 -57,8 10.46% | -61,0 |
|
EPS USD | Released Forecast Spread | -18,5 -15,0 -23.33% | -3,54 -4,00 11.5% | -2,72 -2,82 3.63% | -2,26 -2,48 8.99% | -1,01 -1,22 17.35% | -1,12 |
| Announcement Date | 10/09/19 | 13/10/20 | 15/09/21 | 15/09/22 | 14/09/23 | - |
Quarterly results
| Fiscal Period | Juni | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -12,1 -8,67 -40.21% | -10,8 -15,5 30.66% | -11,3 -14,6 22.58% | -10,2 -12,2 16.06% | -14,4 -15,5 7.41% | -17,1 -15,7 -8.84% | -14,2 -18,2 21.82% | -15,9 -16,5 3.52% | -15,2 -18,1 15.94% | -16,8 | -17,2 | -18,0 | -19,2 | -20,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,6 -8,98 -40.31% | -11,2 -16,2 30.67% | -9,42 -15,1 37.5% | -9,83 -12,4 20.86% | -13,6 -13,5 -0.27% | -15,7 -15,6 -0.51% | -12,7 -18,5 31.21% | -14,5 -16,4 11.25% | -13,9 -16,7 16.57% | -16,2 | -16,1 | -18,0 | -19,2 | -20,4 |
|
Net income Million USD | Released Forecast Spread | -12,6 -8,93 -41% | -11,2 -15,9 29.62% | -9,42 -15,1 37.5% | -9,83 -12,4 20.86% | -13,6 -13,5 -0.27% | -15,7 -15,6 -0.51% | -12,7 -18,5 31.21% | -14,5 -13,5 -7.86% | -13,9 -16,9 17.58% | -16,2 | -16,1 | -18,0 | -19,2 | -20,4 |
|
EPS USD | Released Forecast Spread | -0,80 -0,69 -16.28% | -0,65 -0,91 28.26% | -0,30 -0,56 45.95% | -0,19 -0,31 39.36% | -0,26 -0,32 18.24% | -0,30 -0,30 0% | -0,25 -0,36 29.78% | -0,28 -0,28 0.88% | -0,27 -0,29 6.9% | -0,30 | -0,28 | -0,32 | -0,32 | -0,29 |
| Announcement Date | 09/02/22 | 12/05/22 | 15/09/22 | 09/11/22 | 10/02/23 | 11/05/23 | 14/09/23 | 13/11/23 | 13/02/24 | - | - | - | - | - |
| Today 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 15/05/2024 | CELCUITY INC.: Q1 2024 Earnings Release |
| 16/05/2024 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:30 pm | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 24/07/2024 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
| 25/07/2024 10:30 am | ARGENX SE: Q2 2024 Earnings Release |
| 30/07/2024 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |